| Recruiting | Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma Metastatic Colorectal Carcinoma (mCRC), Colorectal Cancer (CRC), Adenomatous Polyposis Coli (APC) Gene Mutation | Phase 1 / Phase 2 | 2026-02-17 |
| Active Not Recruiting | The Seven Trial: Exploiting the Unfolded Protein Response Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic | Phase 1 | 2025-01-09 |
| Completed | Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations Gastrointestinal Malignancies | Phase 2 | 2022-06-14 |
| Withdrawn | Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas Pancreas Cancer | Phase 2 | 2022-06-14 |
| Completed | Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Mel Uveal Melanoma | Phase 1 | 2022-02-28 |
| Withdrawn | Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma | Phase 1 | 2021-12-31 |
| Completed | Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine Migraine | N/A | 2021-11-11 |
| Completed | Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer Pancreas Cancer | Phase 2 | 2021-10-28 |
| Active Not Recruiting | Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancr Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma | Phase 2 | 2020-12-01 |
| Terminated | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection Covid19 | Phase 2 | 2020-04-20 |
| Completed | Hair Loss Prevention Study for Pancreatic Cancer Alopecia | N/A | 2019-12-13 |
| Terminated | Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabi Metastatic Pancreatic Cancer | Phase 2 | 2019-10-17 |
| Completed | Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients Traumatic Brain Injury | Phase 2 | 2019-09-01 |
| Active Not Recruiting | Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma | Phase 2 | 2019-07-15 |
| Terminated | SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Th Coronary Artery Disease, Atherosclerosis, Stent Placement | Phase 2 | 2018-11-19 |
| Completed | Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in N Jaundice, Neonatal, Neonatal Hyperbilirubinemia, Neonatal Disorder | N/A | 2018-04-15 |
| Completed | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPL Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma | Phase 2 | 2018-01-31 |
| Completed | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable | Phase 1 / Phase 2 | 2017-12-15 |
| Completed | A Standardized Bundle Protocol to Optimize Outcomes With Patients Undergoing Gynecological Surgery Hysterectomy | — | 2017-10-17 |
| Active Not Recruiting | Pre-operative Treatment for Patients With Untreated Pancreatic Cancer Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma | Phase 2 | 2017-05-23 |
| Completed | Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral N Adenocarcinoma of Pancreas | N/A | 2016-05-13 |
| Completed | Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma Untreated Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | 2016-04-01 |